Aching for Improvement: Review of the Gaps and Latest Advances in Osteoarthritis Pain and Other Chronic Pain Management

By clicking the continue button above, I certify I have read the CME/CNE/CPE/AANP/MOC/MIPS statements below.



Release Date: November 13, 2020
Expiration Date: November 13, 2021


PROGRAM DESCRIPTION
Chronic pain, including pain from osteoarthritis (OA), plagues more than half of older adults in the US. In order to help alleviate this pain, primary care physicians (PCPs), NPs, PAs, and pain specialists must be kept up to date with the recommendations for optimal assessment of, goal setting for, and monitoring of patients with OA pain and other chronic pain.

This activity, "Aching for Improvement: Review of the Gaps and Latest Advances in Osteoarthritis Pain and Other Chronic Pain Management", will help clinicians appropriately tailor pain-management plans to their individual patients, including those in special populations, such as the elderly. PCPs, NPs, PAs, and pain specialists will better understand the safety and efficacy profiles of each of the available pain treatment options, along with the unique considerations one must take into account when treating more complex patients.

AGENDA
I. Welcome and Introductions
II. Strategies for diagnosis and initial management of OA and other chronic pain
III. Treatment of elderly patients with OQ and other chronic pain
IV. Emerging NGF inhibitors for the treatment of OA and other chronic pain
V. Concluding Remarks and Q&A

PROGRAM FACULTY
 Timothy J. Atkinson, PharmD, BCPS, CPE
 Clinical Pharmacy Specialist, Pain Management
 Director, PGY2 Pain Management and Palliative Care Residency
 Owner, Vanguard Pain Management Consulting LLC
 Nashville, TN


Timothy J. Atkinson, PharmD, BCPS, CPE is a Clinical Pharmacy Pain Specialist and federal employee in a regional referral pain clinic near Nashville, TN. Dr. Atkinson specializes in complex and high-risk pain medication management through direct patient care and electronic consult services.

He is a Residency Director for a PGY-2 Pain and Palliative Care Pharmacy Residency program and strong advocate for expansion of clinical pharmacists with expertise in collaborative drug therapy management (CDTM) specific to pain management. Dr. Atkinson is the owner of Vanguard Pain Management Consulting, where he advises clients in managed care and the pharmaceutical industry. His research interests include opioid equivalencies, serum-level monitoring, and pain management in specialty disease states and the elderly.

 Steven P. Stanos, DO
 Medical Director, Swedish Health System Pain Medicine and Services
 Past President, American Academy of Pain Medicine
 Seattle, WA




Steven P. Stanos, DO currently serves as Medical Director of Swedish Health System Pain Medicine and Services in Seattle, Washington. Aside from directing pain management services for the hospital system, he also leads Swedish's pain rehabilitation center, Functional Restoration, an integral part of the pain medicine continuum of care. In addition to his work with Swedish Health System, he is active with committees work at Providence St. Joseph Health related to the system integration of pain management including primary and specialty care. Prior to joining Swedish and Providence, he served as medical director of the Center for Pain Management at the Rehabilitation Institute of Chicago (RIC) Northwestern University Medical School from 2002-2014, and served as an Assistant Professor at Northwestern University Feinberg School of Medicine and program-co chair of the multidisciplinary pain fellowship.

Dr. Stanos is board certified in physical medicine and rehabilitation and pain medicine by the American Board of Pain Medicine and by the American Board of Anesthesia.

Dr. Stanos is a Past President of the American Academy of Pain Medicine and serves on the Board of Directors of the American Board of Pain Medicine. He served as a panel member on the Service Delivery and Reimbursement work group for the National Pain Strategy, an invited consultant to the CDC for the CDC Opioid Guideline for Prescribing Opioids for Chronic Pain, and as a work group member for Healthy People 2020 and Healthy People 2030. He is active with the American Academy of Physical Medicine and Rehabilitation and has served as the co- chair of education for the Pain and Neuromuscular Council.

Dr. Stanos’ work also includes ongoing educational initiatives for primary care, pain medicine, and physical medicine specialists around the United States and abroad. Dr. Stanos has published numerous scientific articles and book chapters related to pain management. He has been involved in the development and publication of treatment guidelines related to rehabilitation approaches for chronic pain and low back pain conditions. He also serves on the editorial board for the journal Pain Medicine and as a reviewer for other pain and rehabilitation journals.

A Mayday Foundation Advocacy fellow in 2013, Dr. Stanos's advocacy has continued to focus on increasing awareness and access for inter-disciplinary biopsychosocially-based pain care for patients suffering with chronic pain. In 2014, the University of Washington Department of Pain Medicine awarded Dr. Stanos with the John J. Bonica, MD lecture. He has appeared on CNN, National Public Radio, Fox News, regional print, and television news covering various topics related to pain medicine and pain rehabilitation.

TARGET AUDIENCE
The intended audience for this educational initiative is PCPs, NPs, PAs, Pain Specialists, and additional clinicians who assess and manage patients with Osteoarthritis pain and other chronic pain.

EDUCATIONAL OBJECTIVES
This program is designed to address the following National Academy of Medicine (NAM, formerly Institute of Medicine [IOM]) competencies: provide patient-centered care and employ evidence-based practice.

At the conclusion of this education, participants should be able to:
  • Explain how to assess patients with OA pain and other chronic pain using current screening recommendations and tools  
  • Identify available strategies to facilitate optimal goal setting, and monitoring of patients with OA pain and other chronic pain 
  • Develop effective, personalized OA pain and other chronic pain treatment plans in special populations (e.g. elderly) 
  • Evaluate the safety and efficacy data with the novel nerve growth factor (NGF) inhibitors in clinical development for OA pain and other chronic pain
PHYSICIAN ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Rockpointe Corporation. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN DESIGNATION STATEMENT
Global Education Group designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC DESIGNATION STATEMENT
 Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit

To receive MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through Global Education Group’s Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

For information about ABIM MOC of this program, please email: lknight@globaleducationgroup.com

NURSING CONTINUING EDUCATION
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACIST ACCREDITATION STATEMENT
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



PHARMACIST CREDIT DESIGNATION
Global Education Group designates this continuing education activity for 1.0 contact hours (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-20-024-H01-P).

This is a knowledge-based activity.

NURSE PRACTIONER CONTINUING EDUCATION
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Rockpointe. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1 contact hour which includes 0.2 hours of pharmacology.

MIPS CREDIT DESIGNATION
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

In order to fulfill requirements for MIPS improvement activity, participants will need to fill out 2 brief follow-up surveys at 30- and 90-days post-activity.

PHYSICIAN ASSISTANTS
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category 1 credit for completing this program.

DISCLOSURE OF CONFLICTS OF INTEREST
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
 
Program Faculty
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Timothy J. Atkinson, PharmD, BCPS, CPE: Consultant/Independent Contractor: Axial Healthcare, Inc.; Advisory Committee: Purdue Pharma, LP; Honoraria: Auburn

Steven P. Stanos, DO: Consultant/Independent Contractor: Pfizer, Salix, Sanofi

Non-faculty Content Contributors
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:  

Chelsey Goins, PhD; Ashley Marostica, MSN, RN, CCM; Kristin Delisi, NP; Lindsay Borvansky; Liddy Knight; Andrea Funk; Ashley Cann: Nothing to disclose

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Rockpointe Corporation do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

This course is not intended to advocate for the use of Extended-Release/Long-Acting (ER/LA) Opioids, but to ensure the proper education about safe prescribing practices should a medical provider determine that ER/LA Opioids are the best course of treatment.

HARDWARE/SOFTWARE REQUIREMENTS
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac & Windows): Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/CE CREDIT AND MOC POINTS
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME/CE/MOC activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Jointly provided by Global Education Group and Rockpointe

 


This program is supported through an educational grant from Pfizer Inc and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
 
 
Facebook - RockPointe Twitter - RockPointe LinkedIn - RockPointe